Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine.
New York University Langone Transplant Institute, New York, New York.
Am J Respir Crit Care Med. 2024 Jun 15;209(12):1463-1476. doi: 10.1164/rccm.202309-1551OC.
Acute cellular rejection (ACR) after lung transplant is a leading risk factor for chronic lung allograft dysfunction. Prior studies have demonstrated dynamic microbial changes occurring within the allograft and gut that influence local adaptive and innate immune responses. However, the lung microbiome's overall impact on ACR risk remains poorly understood. To evaluate whether temporal changes in microbial signatures were associated with the development of ACR. We performed cross-sectional and longitudinal analyses (joint modeling of longitudinal and time-to-event data and trajectory comparisons) of 16S rRNA gene sequencing results derived from lung transplant recipient lower airway samples collected at multiple time points. Among 103 lung transplant recipients, 25 (24.3%) developed ACR. In comparing samples acquired 1 month after transplant, subjects who never developed ACR demonstrated lower airway enrichment with several oral commensals (e.g., and spp.) than those with current or future (beyond 1 mo) ACR. However, a subgroup analysis of those who developed ACR beyond 1 month revealed delayed enrichment with oral commensals occurring at the time of ACR diagnosis compared with baseline, when enrichment with more traditionally pathogenic taxa was present. In longitudinal models, dynamic changes in α-diversity (characterized by an initial decrease and a subsequent increase) and in the taxonomic trajectories of numerous oral commensals were more commonly observed in subjects with ACR. Dynamic changes in the lower airway microbiota are associated with the development of ACR, supporting its potential role as a useful biomarker or in ACR pathogenesis.
肺移植后急性细胞排斥(ACR)是慢性肺移植物功能障碍的主要危险因素。先前的研究表明,同种异体移植物和肠道内的微生物会发生动态变化,从而影响局部适应性和先天免疫反应。然而,肺部微生物组对 ACR 风险的总体影响仍知之甚少。为了评估微生物特征的时间变化是否与 ACR 的发展有关。我们对来自 103 名肺移植受者下呼吸道样本的 16S rRNA 基因测序结果进行了横断面和纵向分析(纵向和时间事件数据的联合建模以及轨迹比较)。在 103 名肺移植受者中,有 25 名(24.3%)发生了 ACR。在比较移植后 1 个月采集的样本时,从未发生过 ACR 的受者的下呼吸道中,与当前或未来(超过 1 个月)有 ACR 的受者相比,口腔共生菌(如 和 spp.)的富集度较低。然而,对在 1 个月后发生 ACR 的受者进行亚组分析显示,与基线时相比,在 ACR 诊断时,口腔共生菌的富集延迟,而此时更传统的病原类群的富集则存在。在纵向模型中,具有 ACR 的受者中更常见的是 α-多样性(表现为初始下降和随后增加)和许多口腔共生菌的分类轨迹的动态变化。下呼吸道微生物组的动态变化与 ACR 的发展有关,支持其作为有用的生物标志物或在 ACR 发病机制中的潜在作用。